Wordt geladen...
Long-Term Correction of Sandhoff Disease Following Intravenous Delivery of rAAV9 to Mouse Neonates
G(M2) gangliosidoses are severe neurodegenerative disorders resulting from a deficiency in β-hexosaminidase A activity and lacking effective therapies. Using a Sandhoff disease (SD) mouse model (Hexb(−/−)) of the G(M2) gangliosidoses, we tested the potential of systemically delivered adeno-associate...
Bewaard in:
Gepubliceerd in: | Mol Ther |
---|---|
Hoofdauteurs: | , , , , , , , , , , , |
Formaat: | Artigo |
Taal: | Inglês |
Gepubliceerd in: |
Nature Publishing Group
2015
|
Onderwerpen: | |
Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4351464/ https://ncbi.nlm.nih.gov/pubmed/25515709 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mt.2014.240 |
Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|